Legislative Horizons in Psychedelic Therapy: What Clinicians Need to Know | Fluence
This webinar reviews the current and emerging U.S. policy landscape for psychedelic therapy. It explains how legislation becomes regulation and how clinicians can stay informed about an evolving area without needing to become policy experts.
Course Overview
Legislative Horizons in Psychedelic Therapy: What Clinicians Need to Know is a webinar focused on the policy environment shaping psychedelic therapy in the United States. The session covers how legislation moves into regulation and why early-stage programs often involve uncertainty. The content is geared toward clinicians and therapists who want a clearer understanding of the legal and regulatory context around psychedelic-assisted care. It emphasizes practical awareness rather than deep policy specialization. The course is described as a one-hour webinar. It is presented in a format that helps attendees track policy developments and consider how they may affect clinical practice.
Who is this for?
Clinicians and therapists interested in the policy and regulatory context of psychedelic therapy.
About the Provider
Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.
View Fluence profileCourse Details
- PriceFree
- FormatLive Classes
- Lifecycle statusNo New Dates
- SkillsHarm ReductionIntegrationFacilitationPsychotherapyKetamine-Assisted TherapyPsilocybin TherapyEthicsInterpreting the transition from legislation to regulationRecognizing uncertainty in early-stage programs
You will be redirected to the provider's website